Study design of ASPirin in Reducing Events in the Elderly (ASPREE): A randomized, controlled trial
RH Grimm, JJ McNeil, W Applegate, L Beilin, S Espinoza, C Johnston, B Kirpach, K Margolis, A Murray, MR Nelson, CM Reid, R Shah, E Storey, AM Tonkin, P Wilson, R Wolfe, RL Woods, W Abhayaratna, D Ames, L Cobiac Show all
Contemporary Clinical Trials | ELSEVIER SCIENCE INC | Published : 2013
ASPREE is registered on the International Standard Randomized Controlled Trial Number Register (ISRCTN83772183). ASPREE has received project grants from the National Institute on Aging, the National Health and Medical Research Council (Australia), Heart Foundation (Australia), the National Cancer Institute and the Victorian Cancer Agency (Australia). Bayer Pharma AG provides blinded aspirin and placebo. ASPREE has multiple IRB approvals in the US and Australia.